The falling wedge is a bullish price formation that tells a tale of the stock where bulls are gearing up for a new rally.
+
PFE is trading below my estimate of fair value ($68.47). OVERSOLD!
+ Their Earning is expected to return to the $9-10 billion range (Pre-Covid). The current earning is 2.13 billion.
+ Paxlovid, Prevnar, Elliquis, Ibrance, Xeljanz, Enbrel and Zithromax/Zmax continue to be the most effecitive medications.
+ Pfizer, a company that pays dividends, currently has a yield of 6.21%. I have faith in my chart analysis, however, even if there are inconsistencies, dividends will continue to be distributed, which solidifies its attractiveness as a long-term investment opportunity.
Risk-Free & East Gain
+
+ Their Earning is expected to return to the $9-10 billion range (Pre-Covid). The current earning is 2.13 billion.
+ Paxlovid, Prevnar, Elliquis, Ibrance, Xeljanz, Enbrel and Zithromax/Zmax continue to be the most effecitive medications.
+ Pfizer, a company that pays dividends, currently has a yield of 6.21%. I have faith in my chart analysis, however, even if there are inconsistencies, dividends will continue to be distributed, which solidifies its attractiveness as a long-term investment opportunity.
Risk-Free & East Gain
Nota
Back to TrendlineNota
Going up nowNota
Retesting the Orange line :)Healthy way to go up
Dagangan ditutup: sasaran tercapai
EASYPenafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.